<p>RNS 編號：5091H Oxy Capital - Sgoic, S.A2025 年 11 月 13 日</p>
<p>表格 8.3</p>
<p>公開持倉披露/交易披露由</p>
<p>持有相關證券 1% 或以上權益的個人</p>
<p>收購守則第 8.3 條（&#34;守則&#34;）</p>
<p>1. 關鍵信息</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>(a) 披露者的全名：</td>
<td>Oxy Capital - SGOIC, S.A</td>
</tr>
<tr>
<td>(b) 如果與 1(a) 不同，權益和空頭頭寸的所有者或控制者：</td>
<td></td>
</tr>
<tr>
<td>提名或公司名稱的命名是不夠的。對於信託，必須命名受託人、設立人和受益人。</td>
<td>1. Oxy Capital Liquid Opportunities A - PPR</td>
</tr>
<tr>
<td>2. Oxy Capital Liquid Opportunities B</td>
<td></td>
</tr>
<tr>
<td>(c) 本表格所涉及的要約方/被要約方的名稱：</td>
<td></td>
</tr>
<tr>
<td>每個要約方/被要約方使用單獨的表格</td>
<td>Idox PLC</td>
</tr>
<tr>
<td>(d) 如果是與要約方/被要約方相關的豁免基金經理，請説明並指定要約方/被要約方的身份：</td>
<td>不適用</td>
</tr>
<tr>
<td>(e) 持倉日期/交易日期：</td>
<td></td>
</tr>
<tr>
<td>對於開盤持倉披露，請説明披露前的最新可行日期</td>
<td>2025 年 11 月 13 日</td>
</tr>
<tr>
<td>(f) 除上述 1(c) 的公司外，披露者是否在披露任何其他要約方的相關信息？</td>
<td></td>
</tr>
<tr>
<td>如果是現金要約或可能的現金要約，請説明 “無”</td>
<td>不適用</td>
</tr>
</tbody>
</table>
<p>2. 披露者的持倉情況</p>
<p>如果在要約方或被要約方的相關證券中有多個類別的持倉或認購權需要披露，請為每個額外類別的相關證券複製表格 2(a) 或 (b)（視情況而定）。</p>
<p>(a) 披露的相關證券的權益和空頭頭寸（如有）</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別：</td>
<td>1 便士普通股</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>權益</td>
<td>空頭頭寸</td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>數量</td>
<td>%</td>
<td>數量</td>
<td>%</td>
</tr>
<tr>
<td>(1) 擁有和/或控制的相關證券：</td>
<td>9,852,607</td>
<td>2.13</td>
<td></td>
<td></td>
</tr>
<tr>
<td>(2) 現金結算衍生品：</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>(3) 股票結算衍生品（包括期權）和購買/出售協議：</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>總計：</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<p>所有權益和所有空頭頭寸應予以披露。</p>
<p>任何開放的股票結算衍生品頭寸（包括交易期權）或購買或出售相關證券的協議應在補充表格 8（開放頭寸）中提供詳細信息。</p>
<p>(b) 認購新證券的權利（包括董事和其他員工期權）</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別：</td>
<td>-</td>
</tr>
<tr>
<td>詳細信息，包括相關權利的性質和相關百分比：</td>
<td>-</td>
</tr>
</tbody>
</table>
<p>3. 披露者的交易（如有）</p>
<p>如果在要約方或被要約方的相關證券中有多個類別的交易，請為每個額外類別的相關證券交易複製表格 3(a)、(b)、(c) 或 (d)（視情況而定）。</p>
<p>所有價格和其他貨幣金額的貨幣應予以説明。</p>
<p>(a) 購買和銷售</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別</td>
<td></td>
</tr>
<tr>
<td>購買/銷售</td>
<td>銷售</td>
</tr>
<tr>
<td>證券數量</td>
<td>600,000</td>
</tr>
<tr>
<td>單位價格</td>
<td>70.64157</td>
</tr>
</tbody>
</table>
<p>(b) 現金結算衍生品交易</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別</td>
<td>-</td>
</tr>
<tr>
<td>產品描述</td>
<td></td>
</tr>
<tr>
<td>例如：CFD</td>
<td>-</td>
</tr>
<tr>
<td>交易性質</td>
<td></td>
</tr>
<tr>
<td>例如：開盤/平倉多頭/空頭頭寸，增加/減少多頭/空頭頭寸</td>
<td>-</td>
</tr>
<tr>
<td>參考證券數量</td>
<td>-</td>
</tr>
<tr>
<td>單位價格</td>
<td>-</td>
</tr>
</tbody>
</table>
<p>(c) 股票結算衍生品交易（包括期權）</p>
<p>(i) 寫入、出售、購買或變更</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別</td>
<td>-</td>
</tr>
<tr>
<td>產品描述，例如：看漲期權</td>
<td>-</td>
</tr>
<tr>
<td>寫入、購買、出售、變更等</td>
<td>-</td>
</tr>
<tr>
<td>相關證券數量</td>
<td>-</td>
</tr>
<tr>
<td>單位行使價格</td>
<td>-</td>
</tr>
<tr>
<td>類型</td>
<td></td>
</tr>
<tr>
<td>例如：美式、歐式等</td>
<td>-</td>
</tr>
<tr>
<td>到期日</td>
<td>-</td>
</tr>
<tr>
<td>每單位支付/收到的期權費用</td>
<td>-</td>
</tr>
</tbody>
</table>
<p>(ii) 行使</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別</td>
<td>-</td>
</tr>
<tr>
<td>產品描述</td>
<td></td>
</tr>
<tr>
<td>例如：看漲期權</td>
<td>-</td>
</tr>
<tr>
<td>行使/被行使</td>
<td>-</td>
</tr>
<tr>
<td>證券數量</td>
<td>-</td>
</tr>
<tr>
<td>單位行使價格</td>
<td>-</td>
</tr>
</tbody>
</table>
<p>(d) 其他交易（包括認購新證券）</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別</td>
<td>-</td>
</tr>
<tr>
<td>交易性質</td>
<td></td>
</tr>
<tr>
<td>例如：認購、轉換</td>
<td>-</td>
</tr>
<tr>
<td>詳細信息</td>
<td>-</td>
</tr>
<tr>
<td>單位價格（如適用）</td>
<td>-</td>
</tr>
</tbody>
</table>
<p>4. 其他信息</p>
<p>(a) 賠償和其他交易安排</p>
<ul>
<li>任何賠償或期權安排的詳細信息，或與披露者和任何要約方或與要約方一致行動的任何人之間的任何協議或理解，可能會誘使其進行或避免進行交易：不可撤銷的承諾和意向書不應包括。如果沒有此類協議、安排或理解，請説明 “無”</li>
<li>無</li>
</ul>
<p>(b) 與期權或衍生品相關的協議、安排或理解</p>
<ul>
<li>披露者與任何其他人之間的任何協議、安排或理解的詳細信息，涉及：（i）任何相關證券在任何期權下的投票權；或（ii）任何衍生品所參考的任何相關證券的投票權或未來的收購或處置：如果沒有此類協議、安排或理解，請説明 “無”</li>
<li>無</li>
</ul>
<p>(c) 附件</p>
<ul>
<li>是否附有補充表格 8（開放頭寸）？</li>
<li>否</li>
</ul>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>披露日期：</td>
<td>2025 年 11 月 13 日</td>
</tr>
<tr>
<td>聯繫人姓名：</td>
<td>Pedro de Almeida</td>
</tr>
<tr>
<td>電話號碼 *：</td>
<td>+351 218209910</td>
</tr>
</tbody>
</table>
<p>根據守則第 8 條的公開披露必須向監管信息服務進行。</p>
<p>面板的市場監測單位可就守則的披露要求進行諮詢，電話：+44 (0) 20 7638 0129.</p>
<ul>
<li>如果披露者是自然人，則無需包含電話號碼，前提是已向小組的市場監管單位提供了聯繫信息。</li>
</ul>
<p>該規範可在小組的網站 www.thetakeoverpanel.org.uk 上查看。</p>
<p>此信息由倫敦證券交易所的新聞服務 RNS 提供。RNS 獲得金融行為監管局的批准，作為英國的主要信息提供者。有關使用和分發此信息的條款和條件可能適用。如需更多信息，請聯繫 rns@lseg.com 或訪問 www.rns.com。</p>
<p>RNS 可能會使用您的 IP 地址以確認遵守條款和條件，分析您與此通信中包含的信息的互動方式，並將此類分析以匿名方式與他人共享，作為我們商業服務的一部分。如需瞭解 RNS 和倫敦證券交易所如何使用您提供的個人數據，請參閲我們的隱私政策。END RETGPGRPGUPAGRW</p>

IDOX

<p>Oxy Capital - Sgoic, S.A 公開披露其在 Idox PLC 的持股情況，持有 2.13% 的 1p 普通股。該披露是根據收購守則第 8.3 條進行的。Oxy Capital 報告以每單位 70.64157 的價格出售了 600,000 股。沒有報告其他協議或安排</p>

<p>RNS Number : 5091H Oxy Capital - Sgoic, S.A 13 November 2025</p>
<div class="lb-trans"><p>RNS 編號：5091H Oxy Capital - Sgoic, S.A2025 年 11 月 13 日</p>
</div><p>FORM 8.3</p>
<div class="lb-trans"><p>表格 8.3</p>
</div><p>PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY</p>
<div class="lb-trans"><p>公開持倉披露/交易披露由</p>
</div><p>A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE</p>
<div class="lb-trans"><p>持有相關證券 1% 或以上權益的個人</p>
</div><p>Rule 8.3 of the Takeover Code (the &#34;Code&#34;)</p>
<div class="lb-trans"><p>收購守則第 8.3 條（&#34;守則&#34;）</p>
</div><p>1. KEY INFORMATION</p>
<div class="lb-trans"><p>1. 關鍵信息</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>(a) Full name of discloser:</td>
<td>Oxy Capital - SGOIC, S.A</td>
</tr>
<tr>
<td>(b) Owner or controller of interests and short positions disclosed, if different from 1(a):<br/>The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.</td>
<td>1. Oxy Capital Liquid Opportunities A - PPR<br/>2. Oxy Capital Liquid Opportunities B</td>
</tr>
<tr>
<td>(c) Name of offeror/offeree in relation to whose relevant securities this form relates:<br/>Use a separate form for each offeror/offeree</td>
<td>Idox PLC</td>
</tr>
<tr>
<td>(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:</td>
<td>N/A</td>
</tr>
<tr>
<td>(e) Date position held/dealing undertaken:<br/>For an opening position disclosure, state the latest practicable date prior to the disclosure</td>
<td>13 November 2025</td>
</tr>
<tr>
<td>(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?<br/>If it is a cash offer or possible cash offer, state &#34;N/A&#34;</td>
<td>N/A</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>(a) 披露者的全名：</td>
<td>Oxy Capital - SGOIC, S.A</td>
</tr>
<tr>
<td>(b) 如果與 1(a) 不同，權益和空頭頭寸的所有者或控制者：</td>
<td></td>
</tr>
<tr>
<td>提名或公司名稱的命名是不夠的。對於信託，必須命名受託人、設立人和受益人。</td>
<td>1. Oxy Capital Liquid Opportunities A - PPR</td>
</tr>
<tr>
<td>2. Oxy Capital Liquid Opportunities B</td>
<td></td>
</tr>
<tr>
<td>(c) 本表格所涉及的要約方/被要約方的名稱：</td>
<td></td>
</tr>
<tr>
<td>每個要約方/被要約方使用單獨的表格</td>
<td>Idox PLC</td>
</tr>
<tr>
<td>(d) 如果是與要約方/被要約方相關的豁免基金經理，請説明並指定要約方/被要約方的身份：</td>
<td>不適用</td>
</tr>
<tr>
<td>(e) 持倉日期/交易日期：</td>
<td></td>
</tr>
<tr>
<td>對於開盤持倉披露，請説明披露前的最新可行日期</td>
<td>2025 年 11 月 13 日</td>
</tr>
<tr>
<td>(f) 除上述 1(c) 的公司外，披露者是否在披露任何其他要約方的相關信息？</td>
<td></td>
</tr>
<tr>
<td>如果是現金要約或可能的現金要約，請説明 “無”</td>
<td>不適用</td>
</tr>
</tbody>
</table>
</div><p>2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE</p>
<div class="lb-trans"><p>2. 披露者的持倉情況</p>
</div><p>If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.</p>
<div class="lb-trans"><p>如果在要約方或被要約方的相關證券中有多個類別的持倉或認購權需要披露，請為每個額外類別的相關證券複製表格 2(a) 或 (b)（視情況而定）。</p>
</div><p>(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)</p>
<div class="lb-trans"><p>(a) 披露的相關證券的權益和空頭頭寸（如有）</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Class of relevant security:</td>
<td>1p Ordinary Shares</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>Interests</td>
<td>Short positions</td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>Number</td>
<td>%</td>
<td>Number</td>
<td>%</td>
</tr>
<tr>
<td>(1) Relevant securities owned and/or controlled:</td>
<td>9,852,607</td>
<td>2.13</td>
<td></td>
<td></td>
</tr>
<tr>
<td>(2) Cash-settled derivatives:</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>(3) Stock-settled derivatives (including options) and agreements to purchase/sell:</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>TOTAL:</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別：</td>
<td>1 便士普通股</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>權益</td>
<td>空頭頭寸</td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>數量</td>
<td>%</td>
<td>數量</td>
<td>%</td>
</tr>
<tr>
<td>(1) 擁有和/或控制的相關證券：</td>
<td>9,852,607</td>
<td>2.13</td>
<td></td>
<td></td>
</tr>
<tr>
<td>(2) 現金結算衍生品：</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>(3) 股票結算衍生品（包括期權）和購買/出售協議：</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>總計：</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</div><p>All interests and all short positions should be disclosed.</p>
<div class="lb-trans"><p>所有權益和所有空頭頭寸應予以披露。</p>
</div><p>Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).</p>
<div class="lb-trans"><p>任何開放的股票結算衍生品頭寸（包括交易期權）或購買或出售相關證券的協議應在補充表格 8（開放頭寸）中提供詳細信息。</p>
</div><p>(b) Rights to subscribe for new securities (including directors' and other employee options)</p>
<div class="lb-trans"><p>(b) 認購新證券的權利（包括董事和其他員工期權）</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Class of relevant security in relation to which subscription right exists:</td>
<td>-</td>
</tr>
<tr>
<td>Details, including nature of the rights concerned and relevant percentages:</td>
<td>-</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別：</td>
<td>-</td>
</tr>
<tr>
<td>詳細信息，包括相關權利的性質和相關百分比：</td>
<td>-</td>
</tr>
</tbody>
</table>
</div><p>3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE</p>
<div class="lb-trans"><p>3. 披露者的交易（如有）</p>
</div><p>Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.</p>
<div class="lb-trans"><p>如果在要約方或被要約方的相關證券中有多個類別的交易，請為每個額外類別的相關證券交易複製表格 3(a)、(b)、(c) 或 (d)（視情況而定）。</p>
</div><p>The currency of all prices and other monetary amounts should be stated.</p>
<div class="lb-trans"><p>所有價格和其他貨幣金額的貨幣應予以説明。</p>
</div><p>(a) Purchases and sales</p>
<div class="lb-trans"><p>(a) 購買和銷售</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Class of relevant security</td>
<td></td>
</tr>
<tr>
<td>Purchase/sale</td>
<td>Sale</td>
</tr>
<tr>
<td>Number of securities</td>
<td>600,000</td>
</tr>
<tr>
<td>Price per unit</td>
<td>70.64157</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別</td>
<td></td>
</tr>
<tr>
<td>購買/銷售</td>
<td>銷售</td>
</tr>
<tr>
<td>證券數量</td>
<td>600,000</td>
</tr>
<tr>
<td>單位價格</td>
<td>70.64157</td>
</tr>
</tbody>
</table>
</div><p>(b) Cash-settled derivative transactions</p>
<div class="lb-trans"><p>(b) 現金結算衍生品交易</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Class of relevant security</td>
<td>-</td>
</tr>
<tr>
<td>Product description<br/>e.g. CFD</td>
<td>-</td>
</tr>
<tr>
<td>Nature of dealing<br/>e.g. opening/closing a long/short position, increasing/reducing a long/short position</td>
<td>-</td>
</tr>
<tr>
<td>Number of reference securities</td>
<td>-</td>
</tr>
<tr>
<td>Price per unit</td>
<td>-</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別</td>
<td>-</td>
</tr>
<tr>
<td>產品描述</td>
<td></td>
</tr>
<tr>
<td>例如：CFD</td>
<td>-</td>
</tr>
<tr>
<td>交易性質</td>
<td></td>
</tr>
<tr>
<td>例如：開盤/平倉多頭/空頭頭寸，增加/減少多頭/空頭頭寸</td>
<td>-</td>
</tr>
<tr>
<td>參考證券數量</td>
<td>-</td>
</tr>
<tr>
<td>單位價格</td>
<td>-</td>
</tr>
</tbody>
</table>
</div><p>(c) Stock-settled derivative transactions (including options)</p>
<div class="lb-trans"><p>(c) 股票結算衍生品交易（包括期權）</p>
</div><p>(i) Writing, selling, purchasing or varying</p>
<div class="lb-trans"><p>(i) 寫入、出售、購買或變更</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Class of relevant security</td>
<td>-</td>
</tr>
<tr>
<td>Product description e.g. call option</td>
<td>-</td>
</tr>
<tr>
<td>Writing, purchasing, selling, varying etc.</td>
<td>-</td>
</tr>
<tr>
<td>Number of securities to which option relates</td>
<td>-</td>
</tr>
<tr>
<td>Exercise price per unit</td>
<td>-</td>
</tr>
<tr>
<td>Type<br/>e.g. American, European etc.</td>
<td>-</td>
</tr>
<tr>
<td>Expiry date</td>
<td>-</td>
</tr>
<tr>
<td>Option money paid/ received per unit</td>
<td>-</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別</td>
<td>-</td>
</tr>
<tr>
<td>產品描述，例如：看漲期權</td>
<td>-</td>
</tr>
<tr>
<td>寫入、購買、出售、變更等</td>
<td>-</td>
</tr>
<tr>
<td>相關證券數量</td>
<td>-</td>
</tr>
<tr>
<td>單位行使價格</td>
<td>-</td>
</tr>
<tr>
<td>類型</td>
<td></td>
</tr>
<tr>
<td>例如：美式、歐式等</td>
<td>-</td>
</tr>
<tr>
<td>到期日</td>
<td>-</td>
</tr>
<tr>
<td>每單位支付/收到的期權費用</td>
<td>-</td>
</tr>
</tbody>
</table>
</div><p>(ii) Exercise</p>
<div class="lb-trans"><p>(ii) 行使</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Class of relevant security</td>
<td>-</td>
</tr>
<tr>
<td>Product description<br/>e.g. call option</td>
<td>-</td>
</tr>
<tr>
<td>Exercising/ exercised against</td>
<td>-</td>
</tr>
<tr>
<td>Number of securities</td>
<td>-</td>
</tr>
<tr>
<td>Exercise price per unit</td>
<td>-</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別</td>
<td>-</td>
</tr>
<tr>
<td>產品描述</td>
<td></td>
</tr>
<tr>
<td>例如：看漲期權</td>
<td>-</td>
</tr>
<tr>
<td>行使/被行使</td>
<td>-</td>
</tr>
<tr>
<td>證券數量</td>
<td>-</td>
</tr>
<tr>
<td>單位行使價格</td>
<td>-</td>
</tr>
</tbody>
</table>
</div><p>(d) Other dealings (including subscribing for new securities)</p>
<div class="lb-trans"><p>(d) 其他交易（包括認購新證券）</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Class of relevant security</td>
<td>-</td>
</tr>
<tr>
<td>Nature of dealing<br/>e.g. subscription, conversion</td>
<td>-</td>
</tr>
<tr>
<td>Details</td>
<td>-</td>
</tr>
<tr>
<td>Price per unit (if applicable)</td>
<td>-</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>相關證券類別</td>
<td>-</td>
</tr>
<tr>
<td>交易性質</td>
<td></td>
</tr>
<tr>
<td>例如：認購、轉換</td>
<td>-</td>
</tr>
<tr>
<td>詳細信息</td>
<td>-</td>
</tr>
<tr>
<td>單位價格（如適用）</td>
<td>-</td>
</tr>
</tbody>
</table>
</div><p>4. OTHER INFORMATION</p>
<div class="lb-trans"><p>4. 其他信息</p>
</div><p>(a) Indemnity and other dealing arrangements</p>
<div class="lb-trans"><p>(a) 賠償和其他交易安排</p>
</div><ul>
<li>Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state &#34;none&#34;</li>
<li>none</li>
</ul>
<div class="lb-trans"><ul>
<li>任何賠償或期權安排的詳細信息，或與披露者和任何要約方或與要約方一致行動的任何人之間的任何協議或理解，可能會誘使其進行或避免進行交易：不可撤銷的承諾和意向書不應包括。如果沒有此類協議、安排或理解，請説明 “無”</li>
<li>無</li>
</ul>
</div><p>(b) Agreements, arrangements or understandings relating to options or derivatives</p>
<div class="lb-trans"><p>(b) 與期權或衍生品相關的協議、安排或理解</p>
</div><ul>
<li>Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state &#34;none&#34;</li>
<li>none</li>
</ul>
<div class="lb-trans"><ul>
<li>披露者與任何其他人之間的任何協議、安排或理解的詳細信息，涉及：（i）任何相關證券在任何期權下的投票權；或（ii）任何衍生品所參考的任何相關證券的投票權或未來的收購或處置：如果沒有此類協議、安排或理解，請説明 “無”</li>
<li>無</li>
</ul>
</div><p>(c) Attachments</p>
<div class="lb-trans"><p>(c) 附件</p>
</div><ul>
<li>Is a Supplemental Form 8 (Open Positions) attached?</li>
<li>NO</li>
</ul>
<div class="lb-trans"><ul>
<li>是否附有補充表格 8（開放頭寸）？</li>
<li>否</li>
</ul>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>Date of disclosure:</td>
<td>13/11/2025</td>
</tr>
<tr>
<td>Contact name:</td>
<td>Pedro de Almeida</td>
</tr>
<tr>
<td>Telephone number*:</td>
<td>+351 218209910</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>披露日期：</td>
<td>2025 年 11 月 13 日</td>
</tr>
<tr>
<td>聯繫人姓名：</td>
<td>Pedro de Almeida</td>
</tr>
<tr>
<td>電話號碼 *：</td>
<td>+351 218209910</td>
</tr>
</tbody>
</table>
</div><p>Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.</p>
<div class="lb-trans"><p>根據守則第 8 條的公開披露必須向監管信息服務進行。</p>
</div><p>The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0) 20 7638 0129.</p>
<div class="lb-trans"><p>面板的市場監測單位可就守則的披露要求進行諮詢，電話：+44 (0) 20 7638 0129.</p>
</div><p>*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.</p>
<div class="lb-trans"><ul>
<li>如果披露者是自然人，則無需包含電話號碼，前提是已向小組的市場監管單位提供了聯繫信息。</li>
</ul>
</div><p>The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.</p>
<div class="lb-trans"><p>該規範可在小組的網站 www.thetakeoverpanel.org.uk 上查看。</p>
</div><p>This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.</p>
<div class="lb-trans"><p>此信息由倫敦證券交易所的新聞服務 RNS 提供。RNS 獲得金融行為監管局的批准，作為英國的主要信息提供者。有關使用和分發此信息的條款和條件可能適用。如需更多信息，請聯繫 rns@lseg.com 或訪問 www.rns.com。</p>
</div><p>RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END RETGPGRPGUPAGRW</p>
<div class="lb-trans"><p>RNS 可能會使用您的 IP 地址以確認遵守條款和條件，分析您與此通信中包含的信息的互動方式，並將此類分析以匿名方式與他人共享，作為我們商業服務的一部分。如需瞭解 RNS 和倫敦證券交易所如何使用您提供的個人數據，請參閲我們的隱私政策。END RETGPGRPGUPAGRW</p>
</div>

REG - Oxy Capital - Sgoic IDOX PLC - 表格 8.3 - Idox plc